| Message: | 1.PharmaLegacy Laboratories (Shanghai) Co., Ltdis a company with Osteoporosis Model coup,Humanized miceandHumanized mouse model as the main business. We are committed to providing quality service of AutoimmuneDiseasesModel. PharmaLegacy Laboratories (Shanghai) Co., Ltdwas established in 10 years ago, As a company with a high sense of social responsibility, PharmaLegacyhas established a high reputation for superior quality and expertise in Non-Human Primates Capabilityfield
2.PharmaLegacy Laboratories (Shanghai) Co., Ltdis committed to the continuous improvement of theOsteoarthritis Modelservice, become a society, customers, shareholders and employees long-term trust of the company. Our Company adhering to pirit of for the sake of customers, and win-win with customers , and through PharmaLegacy staff continuous innovation and development to provide first-class Osteoporosis Model the difference,Osteoporosis Model of the market,Osteoporosis Model expense standard,Osteoporosis Model manufacturers spot for enterprises , is what we have been working for. Details:Bone provides protection to visceral organs, storage of minerals, locomotive movement and are the locations of hematopoiesis. Structural integrity of bone can be affected by factors of aging, dietary imbalance, disuse, environmental contamination, infections, medicine, metabolic disorders, physical loading, radiation, smoking and trauma. Efficacy and safety data of the developing therapeutics to osteoporosis model is required to predict the effects in human for excluding the toxicity of it. Bone fragility increases with age in both genders, and most notably after menopause in female. Anti-resorptive agents are well established, such as bisphosphonates, SERMs and likely anti-RANKL antibodies. Anabolic agents are actively being developed. Besides PTH analogues and stem cells, molecules from BMP family and Wnt signal pathways, such as Smads, ERK, Dkk-1, Runx2, and beta-catenin are targets for therapeutics. Safe |
my account
